Cytiva

Cytiva is a global biotechnology leader providing comprehensive life sciences solutions including bioprocessing equipment, consumables, and services for therapeutic development and manufacturing. The company offers leading life sciences brands such as ÄKTA, Amersham, HyClone, MabSelect and Whatman, serving biopharmaceutical companies in antibody production, mRNA manufacturing, cell therapy manufacturing, and viral vector production. Cytiva specializes in advanced therapeutics with expertise in upstream and downstream processing, filtration technologies, chromatography systems, and analytical solutions that support customers from research through commercial manufacturing. Recent innovations include certified biobased resins for sustainable lab filtration, CAR-T cell therapy development solutions, flagship protein A resins for clinical and commercial scenarios, AI-accelerated cell line development partnerships, and new ÄKTA readyflux systems for smaller scale manufacturing. The company serves major pharmaceutical and biotechnology companies worldwide, providing critical infrastructure and expertise to accelerate the development and production of life-changing therapeutics across multiple therapeutic modalities including monoclonal antibodies, mRNA vaccines, cell therapies, and gene therapies.